Evidence map›Paper›PMID 30186383›Full record

ArticleExperimental and therapeutic medicine2018

Effect of naproxen on proliferation and differentiation of primary cell cultures isolated from human cartilage tissue.

Numan Karaarslan, Ahmet Guray Batmaz, Ibrahim Yilmaz, Hanefi Ozbek, Tezcan Caliskan, Duygu Yasar Sirin, Necati Kaplan, Kadir Oznam, Ozkan Ates

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Numan KaraarslanDepartment of Neurosurgery, School of Medicine, Namik Kemal University, Tekirdag 59100, Turkey.
Ahmet Guray BatmazDepartment of Orthopaedics and Traumatology, Atasehir Hospital, Istanbul 34384, Turkey.
Ibrahim YilmazDepartment of Medical Pharmacology, School of Medicine, Istanbul Medipol University, Istanbul 34810, Turkey.
Hanefi OzbekDepartment of Medical Pharmacology, School of Medicine, Istanbul Medipol University, Istanbul 34810, Turkey.
Tezcan CaliskanDepartment of Neurosurgery, School of Medicine, Namik Kemal University, Tekirdag 59100, Turkey.
Duygu Yasar SirinDepartment of Molecular Biology and Genetics, Faculty of Arts and Sciences, Namik Kemal University, Tekirdag 59100, Turkey.
Necati KaplanDepartment of Neurosurgery, Istanbul Rumeli University, Corlu Reyap Hospital, Tekirdag 59100, Turkey.
Kadir OznamDepartment of Orthopaedics and Traumatology, School of Medicine, Istanbul Medipol University, Istanbul 34214, Turkey.
Ozkan AtesDepartment of Neurosurgery, Istanbul Esenyurt University, Esencan Hospital, Istanbul 34510, Turkey.
Istanbul Medipol University · TRNamık Kemal University · TRİstanbul Esenyurt ÜniversitesiTC İstanbul Rumeli Üniversitesi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) that are applied through oral, injectable or topical routes have been widely used in painful and inflammatory musculoskeletal diseases. The current study aimed to determine whether naproxen, an aryl acetic acid derivative with analgesic and anti-inflammatory effects, has a toxic effect on human chondrocytes. Samples containing monolayer primary chondrocyte cultures were prepared following resection from osteochondral tissues obtained from patients with gonarthrosis. Cell viability, toxicity and proliferation and levels of stage-specific embryonic antigen-1, a precursor to human prechondrocytes, were evaluated spectrophotometrically. The results from the untreated control group were compared with those of the study groups, where naproxen was administered in varying doses (1-1,000 µM). Surface morphologies of the cells were compared using inverted light and environmental scanning electron microscopy. Treatment groups were compared by analysis of variance with Tukey's honest difference post hoc test. P<0.01 was considered to indicate a statistically significant difference. The research revealed significant changes to proliferation and differentiation of chondrocytes in all treatment groups (P<0.01). Naproxen was demonstrated to suppress chondrocyte proliferation and differentiation, which may be an important factor to consider when prescribing this medication to patients.

Indexed as

aryl acetic acidchondrotoxicityproliferationstage-specific embryonic antigen-1

Identifiers

PMID30186383
PMCPMC6122143
OpenAlexW2810405085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.